These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6346846)

  • 1. Clinical efficacy and safety of indapamide in essential hypertension.
    Morledge JH
    Am Heart J; 1983 Jul; 106(1 Pt 2):229-32. PubMed ID: 6346846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term experience with indapamide.
    Beling S; Vukovich RA; Neiss ES; Zisblatt M; Webb E; Losi M
    Am Heart J; 1983 Jul; 106(1 Pt 2):258-62. PubMed ID: 6346848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide.
    Plante GE; Dessurault DL
    Am J Med; 1988 Jan; 84(1B):98-103. PubMed ID: 3341391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indapamide in the treatment of essential arterial hypertension: results of a controlled study.
    Plante GE; Robillard C
    Curr Med Res Opin; 1983; 8 Suppl 3():59-66. PubMed ID: 6352186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension.
    Fiddes R; Blumenthal J; Dawson JE; Dyckman E; St John Hammond PG; Harris S; Lasseter KC; Levine BS; Montoro R; Niederman AL; Ratner PH; Rosenblatt S; Toth PD; Vergis J; Codispoti J
    J Hum Hypertens; 1997 Apr; 11(4):239-44. PubMed ID: 9185029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of indapamide in the treatment of hypertension.
    Anavekar SN; Ludbrooke A; Louis WJ; Doyle AE
    J Cardiovasc Pharmacol; 1979; 1(4):389-94. PubMed ID: 94616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension.
    Spannbrucker N; Achhammer I; Metz P; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):190-3. PubMed ID: 3285833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative trial of indapamide and hydrochlorothiazide in essential hypertension, with forearm plethysmography.
    Kreeft JH; Langlois S; Ogilvie RI
    J Cardiovasc Pharmacol; 1984; 6(4):622-6. PubMed ID: 6206316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indapamide in the stepped-care treatment of obese hypertensive patients.
    Noble RE; Webb EL; Godfrey JC; Zisblatt M; Vukovich RA; Neiss ES
    Curr Med Res Opin; 1983; 8 Suppl 3():93-104. PubMed ID: 6617242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension.
    Capone P; Vukovich RA; Neiss ES; Bolton S; Reeves RL
    Clin Ther; 1983; 5(3):305-16. PubMed ID: 6342786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind comparison of indapamide with a placebo in hypertensive patients treated by practicing physicians.
    Schaller MD; Waeber B; Brunner HR
    Clin Exp Hypertens A; 1985; 7(7):985-94. PubMed ID: 3899418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and safety of indapamide in the treatment of edema.
    Slotkoff L
    Am Heart J; 1983 Jul; 106(1 Pt 2):233-7. PubMed ID: 6869205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion from 2.5 mg to 1.25 mg indapamide in patients with mild to moderate hypertension.
    Levine B; Lee W; Boyd G; Chrysant S; Dawson J; Gardner T; Hill G; Vergis J; Codispoti J; Stokes A
    J Fam Pract; 1995 Jul; 41(1):75-80. PubMed ID: 7798068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic benefit of a low dose of indapamide: results of a double-blind against placebo European controlled study].
    Asmar R; Guez D; Malbezin M; Brault Y; de Cordoue A; Barrandon S; Bruxelles MC; Chastang C
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1083-7. PubMed ID: 8572850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
    Ambrosioni E; Safar M; Degaute JP; Malin PL; MacMahon M; Pujol DR; de Cordoüe A; Guez D
    J Hypertens; 1998 Nov; 16(11):1677-84. PubMed ID: 9856369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes.
    Kuo SW; Pei-Dee ; Hung YJ; Hsieh AT; Wu LY; Hsieh CH; He CT; Yang TC; Lian WC
    Am J Hypertens; 2003 Aug; 16(8):623-8. PubMed ID: 12878366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the activity of a new agent, indapamide, in essential arterial hypertension.
    Hatt PY; Leblond JB
    Curr Med Res Opin; 1975; 3(3):138-44. PubMed ID: 1097194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indapamide in the treatment of hypertension in non-insulin-dependent diabetes.
    Raggi U; Palumbo P; Moro B; Bevilacqua M; Norbiato G
    Hypertension; 1985; 7(6 Pt 2):II157-60. PubMed ID: 4077234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indapamide: clinical pharmacology, therapeutic efficacy in hypertension, and adverse effects.
    Mroczek WJ
    Pharmacotherapy; 1983; 3(2 Pt 1):61-7. PubMed ID: 6856486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.